YOLFTbeta
47

Vizionfocus Inc.

4771 · TW · Healthcare / Medical Instruments & Supplies

178.50TWD+1.00 (+0.56%)

Price History

Full chart

Market Stats

Previous Close177.50
Open178.00
Day Range177.50 – 181.00
52-Week Range161.50 – 220.00
Volume119.65K
Market Cap12.57B
P/E (TTM)14.16
Forward P/E0.00
EPS15.11
Dividend Yield3.26%
Beta0.67
50-Day Avg204.17
200-Day Avg191.19

About

Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, OEM, development, and sale of contact lenses, as well as customized services. Vizionfocus Inc. was founded in 2012 and is headquartered in Miaoli, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEODr. Angus Shi
  • Employees0
  • HeadquartersNo. 66, Youyi Road, Miaoli, Taiwan, 35059, Taiwan
  • Websitehttps://www.vizionfocus.com

Leadership

  • Dr. Angus ShiGM & Director
  • Sofia LeeCFO & Corporate Governance Officer
  • Xingjuan LiAccounting Supervisor
  • Peter SuChief Information Security Officer
  • Chia-Hua ChangGeneral Manager of Vizionfocus Inc., (Jiang Su)

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue584.86M855.15M1.42B1.83B2.57B3.00B3.49B
Growth (%)-+46.21%+66.02%+29.21%+40.23%+16.71%+16.17%
Cost of Revenue398.63M566.45M927.88M1.14B1.55B1.82B2.06B
Gross Profit186.24M288.70M491.81M697.43M1.03B1.18B1.43B
Gross Margin31.84%33.76%34.64%38.02%39.86%39.27%40.89%
Operating Expense105.55M134.82M160.59M182.78M193.32M306.76M420.03M
Operating Income80.68M153.88M331.23M514.65M832.02M872.15M1.01B
Operating Margin13.80%17.99%23.33%28.06%32.35%29.05%28.85%
EBITDA141.35M292.35M500.02M748.91M1.13B1.30B1.42B
EBITDA Margin24.17%34.19%35.22%40.83%44.06%43.45%40.58%
Net Income120.32M146.37M234.13M312.99M562.28M669.59M740.77M
Net Income Margin20.57%17.12%16.49%17.06%21.86%22.30%21.24%
R&D35.98M52.48M86.12M99.47M127.22M145.18M174.41M
R&D as % of Total Revenue6.15%6.14%6.07%5.42%4.95%4.84%5.00%
Interest Expense5.47M11.41M9.53M12.67M19.97M28.84M26.26M
Interest Expense % of Total Revenue0.94%1.33%0.67%0.69%0.78%0.96%0.75%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-2.19B2.89B3.21B4.46B5.94B7.06B
Total Liabilities-894.21M1.08B1.19B2.43B2.09B2.64B
Total Equity-1.01B1.42B1.64B1.79B3.53B3.98B
Cash-305.41M580.88M918.50M800.16M1.18B989.44M
Total Debt-745.87M785.18M763.60M1.73B1.34B1.59B
Net Debt-440.47M204.30M-154.90M929.38M155.05M597.41M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.40M75.81M388.97M757.76M958.65M1.14B1.07B
Investing Cash Flow-407.55M-422.92M-392.68M-288.21M-1.39B-1.21B-1.23B
Financing Cash Flow535.50M390.53M280.26M-133.98M325.25M426.19M-47.06M
Capital Expenditure386.83M389.39M440.58M292.07M1.39B946.41M1.15B
Free Cash Flow-363.44M-313.58M-51.61M465.69M-435.20M197.41M-78.24M
Dividends Paid---78.01M130.02M187.26M322.64M
FCF to OCF-1553.28%-413.62%-13.27%61.46%-45.40%17.26%-7.29%
Dividend Paid to FCF---16.75%-29.88%94.86%-412.38%

Earnings

Report DateMay 14, 2024Aug 13, 2024Nov 13, 2024Mar 10, 2025May 13, 2025Aug 12, 2025Nov 10, 2025Mar 13, 2026Mar 31, 2026Aug 11, 2026
EPS Estimate3.103.423.212.792.873.183.133.323.794.28
EPS Actual3.342.962.462.863.272.563.273.513.634.71
Surprise7.74%-13.45%-23.36%2.51%13.94%-19.50%4.47%5.72%-4.30%10.05%
TimingPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hours

Key Statistics & Ratios

Market Cap12.57B
Enterprise Value13.53B
Trailing P/E14.16
Forward P/E0.00
Price / Sales3.12
Price / Book3.09
EPS15.11
Book Value70.54
Revenue (TTM)4.03B
Gross Profit (TTM)1.68B
EBITDA1.57B
Profit Margin22.11%
Operating Margin30.95%
Return on Equity23.51%
Return on Assets10.15%
Shares Outstanding58.73M
Shares Float31.75M
Beta0.67
Dividend Yield3.26%
Dividend Rate6.97
Payout Ratio46.11%

Dividends

20261×
6.97Jul 24, 2026
20251×
5.52Jul 10, 2025
20241×
3.23Jul 10, 2024
20231×
2.50Jul 6, 2023
20221×
1.50Aug 4, 2022